Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
LongevityReviews.org
Evidence Consensus Engine
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensusbronze • 83/100

High-Polyphenol Extra Virgin Olive Oil (Oleocanthal)Raw, cold-pressed Extra Virgin Olive Oil containing high concentrations of Oleocanthal and Hydroxytyrosol operates as a direct therapeutic agent. Oleocanthal is a phenolic compound that exhibits potent anti-inflammatory properties by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes—mechanistically mirroring the action of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen25. Concurrently, Hydroxytyrosol neutralizes DNA oxidation markers (e.g., 8-OHdG) and stimulates cellular repair pathways25. Dosed at 15mL-30mL daily, high-phenolic EVOO provides satiety, modulates lipid metabolism, and serves as the perfect biological carrier matrix for lipophilic longevity molecules like resveratrol and fisetin26.

Knowledge Graph:Vector: HeartInflammaging
Head-to-Head CompareAudit in Stack
Supplements & NutraceuticalsHeartBronze Tier75–84Emerging Confidence⚖️ Scientific Consensus: Stable

High-Polyphenol Extra Virgin Olive Oil (EVOO)

Oleocanthal-rich unrefined olive oil acting as a natural COX inhibitor and sirtuin-1 autophagy activator.

83/100
Targeted Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

High-Polyphenol Extra Virgin Olive Oil (Oleocanthal)Raw, cold-pressed Extra Virgin Olive Oil containing high concentrations of Oleocanthal and Hydroxytyrosol operates as a direct therapeutic agent. Oleocanthal is a phenolic compound that exhibits potent anti-inflammatory properties by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes—mechanistically mirroring the action of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen25. Concurrently, Hydroxytyrosol neutralizes DNA oxidation markers (e.g., 8-OHdG) and stimulates cellular repair pathways25. Dosed at 15mL-30mL daily, high-phenolic EVOO provides satiety, modulates lipid metabolism, and serves as the perfect biological carrier matrix for lipophilic longevity molecules like resveratrol and fisetin26.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:29897866

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts (PREDIMED)

OPEN LABEL RCT • Sample: N = 7,447

“Major Adverse Cardiovascular Events (MACE) Hazard Ratio: -30%”

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

“Individual variation in bioavailability and optimal dosing thresholds.”

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Neutral Pathway
0/ 100

No direct primary biochemical modulation of heart health; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Brain Longevity & Cognition

Neutral Pathway
0/ 100

No direct primary biochemical modulation of brain longevity; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Metabolic & Glycemic Health

Neutral Pathway
0/ 100

No direct primary biochemical modulation of metabolic health; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Cancer Defense & Autophagy

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cancer defense; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Endocrine Vitality & Anabolic Tone

Neutral Pathway
0/ 100

No direct primary biochemical modulation of testosterone; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Systemic Inflammation Suppression

Neutral Pathway
0/ 100

No direct primary biochemical modulation of chronic inflammation; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Bone Density & Connective Matrix

Neutral Pathway
0/ 100

No direct primary biochemical modulation of bone density; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Cellular Longevity & Epigenetics

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cellular longevity; pathway is neutral for High-Polyphenol Extra Virgin Olive Oil (EVOO).

Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Endothelial Protection & LDL Oxidation Prevention
Secondary Clinical Endpoints:
Systemic Inflammatory DownregulationAtherosclerotic Plaque StabilizationCognitive Health Preservation
LEVL Recommended Tracking Metrics:
Heart & Cardiovascular Healthinflammationcholesterol

Cardiovascular Longevity

96/99
Very High EffectGrade A (NEJM PREDIMED Landmark RCT)30-50 mL daily consumption
PREDIMED Trial: Extra-Virgin Olive Oil and Cardiovascular EndpointsPMID: 29897866

Clinical Endpoint: Supplementing diets with >4 tablespoons daily of high-polyphenol EVOO reduced composite stroke, heart attack, and cardiovascular death by 30%.

cardiovascular_longevity

Autophagy Induction

85/99
High EffectGrade B (Human Clinical Cohort)2-6 weeks
Oleocanthal and Hydroxytyrosol Trigger SIRT1 Activation and AutophagyPMID: 26601683

Clinical Endpoint: Oleocanthal acts as a natural COX inhibitor and stimulates neuronal autophagy waste clearance.

autophagy_induction
Explainable Longevity Score Decomposition

Score Breakdown: 83 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1.15x
Evidence Strength72/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude94/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit84/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility88/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=7,447 pooled participants) across 72/100 evidence strength and 94/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
<$30 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

High-Polyphenol Extra Virgin Olive Oil (EVOO) Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
7,447
Avg RoB
1.3 / 5
Human Clinical (n=7,447)Open-Label RCTGRADE: Very High
Risk of Bias: 1.3

Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts (PREDIMED)

Estruch R, Ros E, Salas-Salvadó J, et al.•New England Journal of Medicine•2018•N = 7,447•249 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Major Adverse Cardiovascular Events (MACE) Hazard Ratio-30%
-30%p < 0.05
Clinical Takeaway:Rigorous multi-year RCT establishing that high-polyphenol EVOO consumption directly prevents major cardiovascular events and stroke.
Independent Academic Research
PubMed: 29897866DOI
Chronological Evolution of Evidence

High-Polyphenol Extra Virgin Olive Oil (EVOO) Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

High-Polyphenol Extra Virgin Olive Oil (EVOO) Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

  • •None known

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1.15x
Works Well With (Compounding Synergies)
+Fisetin+Quercetin+Vitamin D3 & K2+Curcumin+Nut Pudding

Mechanism:Oleocanthal and oleuropein provide potent anti-inflammatory COX-1/2 inhibition while lipid triglycerides act as the optimal micelle carrier for lipophilic supplements.

May Interfere With (Antagonisms / Blunting)
✕High-Heat Deep Frying (>375°F)

Blunting Rationale:Overheating oxidizes delicate polyphenols and unsaturated fatty acids.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)